[Hub]/) : Traits : Impedance of arm (right) : ← →

chr9:135,883,620-136,399,075

Best TWAS P=1.05e-20 · Best GWAS P=1.09e-17 conditioned to 0.539

Associated models

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
18	The Cancer Genome Atlas	Rectum Adenocarcinoma	ABO	0.48	0.23	enet	10	0.27	4.7e-07	8.4	9.3	1.0e-20	0.89	0.00	0.98	TRUE
15	The Cancer Genome Atlas	Pancreatic Adenocarcinoma	ABO	0.23	0.21	lasso	5	0.20	6.7e-09	8.6	9.0	1.7e-19	0.96	0.00	1.00	FALSE
4	The Cancer Genome Atlas	Colon Adenocarcinoma	ABO	0.27	0.31	blup	43	0.33	2.1e-19	7.7	8.8	1.0e-18	0.87	0.02	0.98	FALSE
23	The Cancer Genome Atlas	Thyroid Carcinoma	ABO	0.44	0.57	enet	18	0.60	1.9e-73	7.8	8.7	3.8e-18	0.97	0.00	1.00	FALSE
11	The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	ABO	0.23	0.23	lasso	2	0.24	2.2e-11	8.6	8.5	1.3e-17	1.00	0.00	1.00	FALSE
7	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	ABO	0.11	0.08	blup	43	0.12	2.5e-13	7.7	8.5	1.9e-17	0.78	0.01	0.99	FALSE
10	The Cancer Genome Atlas	Brain Lower Grade Glioma	ABO	0.26	0.23	enet	10	0.26	6.0e-29	7.8	8.4	6.2e-17	0.87	0.47	0.53	FALSE
9	The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	ABO	0.31	0.38	lasso	5	0.42	3.1e-26	8.6	8.3	1.1e-16	0.97	0.00	1.00	FALSE
16	The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	ABO	0.23	0.23	lasso	3	0.23	2.0e-09	7.7	8.1	4.2e-16	0.95	0.01	0.99	FALSE
12	The Cancer Genome Atlas	Lung Adenocarcinoma	ABO	0.21	0.25	lasso	5	0.25	2.1e-29	7.8	8.1	4.5e-16	0.97	0.01	0.99	FALSE
21	The Cancer Genome Atlas	Stomach Adenocarcinoma	ABO	0.20	0.10	blup	42	0.18	5.8e-13	7.8	8.1	5.3e-16	0.83	0.00	1.00	FALSE
3	The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	ABO	0.11	0.05	blup	43	0.12	1.2e-06	-4.5	8.0	8.6e-16	0.77	0.03	0.97	FALSE
6	The Cancer Genome Atlas	Glioblastoma Multiforme	ABO	0.18	0.01	blup	42	0.07	3.0e-03	7.7	8.0	9.8e-16	0.83	0.00	0.75	FALSE
19	The Cancer Genome Atlas	Soft Tissue Sarcoma	ABO	0.32	0.18	enet	10	0.20	2.3e-12	7.8	8.0	9.9e-16	0.85	0.00	1.00	FALSE
14	The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	ABO	0.28	0.22	lasso	8	0.22	1.2e-14	7.8	7.9	3.0e-15	0.94	0.01	0.99	FALSE
20	The Cancer Genome Atlas	Skin Cutaneous Melanoma	ABO	0.38	0.11	blup	43	0.15	9.6e-05	6.3	7.9	3.8e-15	0.76	0.02	0.85	FALSE
1	The Cancer Genome Atlas	Bladder Urothelial Carcinoma	ABO	0.08	0.01	blup	43	0.07	7.9e-07	7.8	7.8	4.3e-15	0.77	0.01	0.99	FALSE
5	The Cancer Genome Atlas	Esophageal Carcinoma	ABO	0.27	0.13	lasso	2	0.11	1.8e-04	7.7	7.8	8.3e-15	0.93	0.02	0.96	FALSE
2	The Cancer Genome Atlas	Breast Invasive Carcinoma	ABO	0.07	0.08	lasso	3	0.08	5.0e-16	7.8	7.7	1.0e-14	0.93	0.30	0.70	FALSE
17	The Cancer Genome Atlas	Prostate Adenocarcinoma	ABO	0.18	0.15	blup	43	0.21	3.4e-21	8.6	7.7	1.4e-14	0.84	0.00	1.00	FALSE
13	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	ABO	0.08	0.06	blup	43	0.09	1.7e-10	7.8	7.5	5.5e-14	0.88	0.00	1.00	FALSE
8	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	ABO	0.20	0.19	blup	43	0.33	3.0e-38	-4.6	7.2	7.7e-13	0.79	0.61	0.39	FALSE
22	The Cancer Genome Atlas	Testicular Germ Cell Tumors	ABO	0.41	0.17	enet	12	0.25	3.0e-09	-3.4	6.1	9.9e-10	0.87	0.04	0.96	FALSE